ARK Genomic Revolution ETF
ARKG
215 hedge funds and large institutions have $482M invested in ARK Genomic Revolution ETF in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 42 closing their positions.
13% more call options, than puts
Call options by funds: $109M | Put options by funds: $96.5M
1.15% more ownership
Funds ownership: 52.03% → 53.18% (+1.1%)
4% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 56
10% less funds holding
Funds holding: 239 → 215 (-24)
16% less capital invested
Capital invested by funds: $575M → $482M (-$92.6M)
43% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$31.5M |
| 2 |
Citigroup
New York
|
+$22.7M |
| 3 |
JP Morgan Chase
New York
|
+$16.1M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$14.7M |
| 5 |
SG Americas Securities
New York
|
+$2.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$39.6M |
| 2 |
Morgan Stanley
New York
|
-$28.1M |
| 3 |
Two Sigma Investments
New York
|
-$22.6M |
| 4 |
Goldman Sachs
New York
|
-$8.47M |
| 5 |
Jane Street
New York
|
-$7.28M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KBFS
251
Kohmann Bosshard Financial Services
Fairlawn,
Ohio
| – | -$1.65K | -70 | Closed |
|
|
DRP
252
Decker Retirement Planning
Levi,
Utah
| – | -$1.2K | -51 | Closed |
|
|
TCOV
253
Trust Company of Vermont
Brattleboro,
Vermont
| – | -$306 | -13 | Closed |
|
254
Fidelity Investments
Boston,
Massachusetts
| – | -$165 | -7 | Closed |
|
|
CAS
255
Coppell Advisory Solutions
Coppell,
Texas
| – | -$119 | -5 | Closed |
|
|
VWM
256
Vermillion Wealth Management
Rosemount,
Minnesota
| – | -$118 | -5 | Closed |
|
|
PCWA
257
Pacific Capital Wealth Advisors
Corona,
California
| – | -$47 | -2 | Closed |
|
ARKG Hedge Fund Activity: Q1 2025 in Review
215 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2025, worth a combined $482M — down 16% from $575M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ARKG and 24 opened new positions — a net loss of 18 holders — while 56 trimmed existing stakes and 54 added.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $31.5M. The largest seller was Bank of America, cutting an estimated $39.6M.
- 215 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2025, down from 239 in Q4 2024.
- Funds reported $482M of ARK Genomic Revolution ETF stock for Q1 2025, down 16% quarter-over-quarter.
- 24 funds opened new ARK Genomic Revolution ETF positions in Q1 2025 and 42 closed out, a net change of -18 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2025 was BNP Paribas Financial Markets, an estimated $31.5M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2025 was Bank of America, an estimated $39.6M sold.
Based on aggregated 13F filings for Q1 2025.